Combined Inhibition of DYRK1A, SMAD, and Trithorax Pathways Synergizes to Induce Robust Replication in Adult Human Beta Cells.

[1]  Benjamin T Yeh,et al.  CC-401 Promotes &bgr;-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition , 2018, Endocrinology.

[2]  M. Mahajan,et al.  Insights into beta cell regeneration for diabetes via integration of molecular landscapes in human insulinomas , 2017, Nature Communications.

[3]  D. Egli,et al.  β-Cell Replacement in Mice Using Human Type 1 Diabetes Nuclear Transfer Embryonic Stem Cells , 2017, Diabetes.

[4]  Michael B. Elowitz,et al.  Combinatorial Signal Perception in the BMP Pathway , 2017, Cell.

[5]  T. Dunckley,et al.  Dyrk1 inhibition improves Alzheimer's disease‐like pathology , 2017, Aging cell.

[6]  D. E. Brooks,et al.  Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015 , 2016, Journal of Medical Toxicology.

[7]  P. Wang,et al.  Development of a reliable automated screening system to identify small molecules and biologics that promote human β-cell regeneration. , 2016, American journal of physiology. Endocrinology and metabolism.

[8]  J. Schug,et al.  Single-Cell Mass Cytometry Analysis of the Human Endocrine Pancreas. , 2016, Cell metabolism.

[9]  Douglas A. Melton,et al.  Generation of stem cell-derived β-cells from patients with type 1 diabetes , 2016, Nature Communications.

[10]  S. Itzkovitz,et al.  The Genetic Program of Pancreatic β-Cell Replication In Vivo , 2016, Diabetes.

[11]  D. E. Olson,et al.  Inhibition of DYRK1A Stimulates Human β-Cell Proliferation , 2016, Diabetes.

[12]  E. Dirice,et al.  Inhibition of TGF-β Signaling Promotes Human Pancreatic β-Cell Replication , 2016, Diabetes.

[13]  D. Accili,et al.  Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes. , 2016, The Journal of clinical endocrinology and metabolism.

[14]  K. Prasadan,et al.  Transient Suppression of TGFβ Receptor Signaling Facilitates Human Islet Transplantation. , 2016, Endocrinology.

[15]  Austin D. Swafford,et al.  Inhibition of DYRK1A and GSK3B induces human β-cell proliferation , 2015, Nature Communications.

[16]  S. Estrem,et al.  Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway , 2015, Drug design, development and therapy.

[17]  K. Takane,et al.  Early and Late G1/S Cyclins and Cdks Act Complementarily to Enhance Authentic Human β-Cell Proliferation and Expansion , 2015, Diabetes.

[18]  J. Massagué,et al.  Structural determinants of Smad function in TGF-β signaling. , 2015, Trends in biochemical sciences.

[19]  Rohit N. Kulkarni,et al.  Human β-Cell Proliferation and Intracellular Signaling: Part 3 , 2015, Diabetes.

[20]  P. Wang,et al.  Diabetes mellitus—advances and challenges in human β-cell proliferation , 2015, Nature Reviews Endocrinology.

[21]  Peng Wang,et al.  Induction of human pancreatic beta cell replication by inhibitors of dual specificity tyrosine regulated kinase , 2015, Nature Medicine.

[22]  A. Schneyer,et al.  Effects of activin A on survival, function and gene expression of pancreatic islets from non-diabetic and diabetic human donors , 2014, Islets.

[23]  D. Melton,et al.  Generation of Functional Human Pancreatic β Cells In Vitro , 2014, Cell.

[24]  M. Farmen,et al.  A phase I dose-escalation study to a predefined dose of a transforming growth factor-β1 monoclonal antibody (TβM1) in patients with metastatic cancer , 2014, International journal of oncology.

[25]  C. Hill,et al.  TGF-β signaling to chromatin: how Smads regulate transcription during self-renewal and differentiation. , 2014, Seminars in cell & developmental biology.

[26]  K. Prasadan,et al.  M2 macrophages promote beta-cell proliferation by up-regulation of SMAD7 , 2014, Proceedings of the National Academy of Sciences.

[27]  L. Mariani,et al.  PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer: an open label, single-group, phase 2 trial , 2014, Investigational New Drugs.

[28]  K. Kaestner,et al.  Targeting the cell cycle inhibitor p57Kip2 promotes adult human β cell replication. , 2014, The Journal of clinical investigation.

[29]  J. Godbold,et al.  Anti-transforming growth factor-β therapy in patients with myelofibrosis , 2014, Leukemia & lymphoma.

[30]  Mark I. McCarthy,et al.  Pancreatic islet enhancer clusters enriched in type 2 diabetes risk–associated variants , 2013, Nature Genetics.

[31]  K. Prasadan,et al.  A Smad Signaling Network Regulates Islet Cell Proliferation , 2013, Diabetes.

[32]  R. Bottino,et al.  Combined modulation of polycomb and trithorax genes rejuvenates β cell replication. , 2013, The Journal of clinical investigation.

[33]  James A. DeCaprio,et al.  The DREAM complex: master coordinator of cell cycle-dependent gene expression , 2013, Nature Reviews Cancer.

[34]  Amy E. Cox,et al.  Cytoplasmic-Nuclear Trafficking of G1/S Cell Cycle Molecules and Adult Human β-Cell Replication , 2013, Diabetes.

[35]  Amy E. Cox,et al.  Human Pancreatic β-Cell G1/S Molecule Cell Cycle Atlas , 2013, Diabetes.

[36]  G. Rutter,et al.  When less is more: the forbidden fruits of gene repression in the adult β‐cell , 2013, Diabetes, obesity & metabolism.

[37]  D. I. Brierley,et al.  Developments in harmine pharmacology — Implications for ayahuasca use and drug-dependence treatment , 2012, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[38]  F. Pattou,et al.  Adaptive changes of human islets to an obesogenic environment in the mouse , 2012, Diabetologia.

[39]  L. Meijer,et al.  Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B. , 2012, Journal of medicinal chemistry.

[40]  M. Yanagita.  Inhibitors/antagonists of TGF-β system in kidney fibrosis. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[41]  C. Talchai,et al.  Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure , 2012, Cell.

[42]  G. Crabtree,et al.  Neonatal β cell development in mice and humans is regulated by calcineurin/NFAT. , 2012, Developmental cell.

[43]  M. Atkinson,et al.  Formation of a human β-cell population within pancreatic islets is set early in life. , 2012, The Journal of clinical endocrinology and metabolism.

[44]  M. Granvik,et al.  β-Cell–Specific Gene Repression: A Mechanism to Protect Against Inappropriate or Maladjusted Insulin Secretion? , 2012, Diabetes.

[45]  E. Stanley,et al.  INSGFP/w human embryonic stem cells facilitate isolation of in vitro derived insulin-producing cells , 2011, Diabetologia.

[46]  J. Sage,et al.  PDGF signalling controls age-dependent proliferation in pancreatic β-cells , 2011, Nature.

[47]  C. Rhodes,et al.  Specific Glucose-Induced Control of Insulin Receptor Substrate-2 Expression Is Mediated via Ca2+-Dependent Calcineurin/NFAT Signaling in Primary Pancreatic Islet β-Cells , 2011, Diabetes.

[48]  M. Washburn,et al.  DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly. , 2011, Genes & development.

[49]  G. Remuzzi,et al.  A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis , 2011, Kidney international.

[50]  K. Chung,et al.  Dyrk1A Phosphorylates p53 and Inhibits Proliferation of Embryonic Neuronal Cells* , 2010, The Journal of Biological Chemistry.

[51]  A. Schneyer,et al.  Emerging roles for the TGFβ family in pancreatic β-cell homeostasis , 2010, Trends in Endocrinology & Metabolism.

[52]  H. Aburatani,et al.  Promoter‐wide analysis of Smad4 binding sites in human epithelial cells , 2009, Cancer science.

[53]  A. Tarakhovsky,et al.  Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. , 2009, Genes & development.

[54]  A. Bhushan,et al.  Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. , 2009, Genes & development.

[55]  L. Miller,et al.  CDKN1C (p57KIP2) Is a Direct Target of EZH2 and Suppressed by Multiple Epigenetic Mechanisms in Breast Cancer Cells , 2009, PloS one.

[56]  A. F. Stewart,et al.  Survey of the Human Pancreatic β-Cell G1/S Proteome Reveals a Potential Therapeutic Role for Cdk-6 and Cyclin D1 in Enhancing Human β-Cell Replication and Function In Vivo , 2009, Diabetes.

[57]  R. Rizza,et al.  β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans , 2008, Diabetes.

[58]  E. Rosen,et al.  FSTL3 deletion reveals roles for TGF-β family ligands in glucose and fat homeostasis in adults , 2007, Proceedings of the National Academy of Sciences.

[59]  J. Neilson,et al.  Calcineurin/NFAT signalling regulates pancreatic β-cell growth and function , 2006, Nature.

[60]  Xueying Gu,et al.  Conditional Expression of Smad7 in Pancreatic β Cells Disrupts TGF-β Signaling and Induces Reversible Diabetes Mellitus , 2006, PLoS biology.

[61]  O. Rozenblatt-Rosen,et al.  Menin regulates pancreatic islet growth by promoting histone methylation and expression of genes encoding p27Kip1 and p18INK4c. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. Hanahan,et al.  Of Mice and MEN1: Insulinomas in a Conditional Mouse Knockout , 2003, Molecular and Cellular Biology.

[63]  F. Collins,et al.  A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[64]  B. Glaser,et al.  Beta-cell proliferation and apoptosis in the developing normal human pancreas and in hyperinsulinism of infancy. , 2000, Diabetes.

[65]  Y Wang,et al.  Positional cloning of the gene for multiple endocrine neoplasia-type 1. , 1997, Science.

[66]  M. J. MacDonald,et al.  Low lactate dehydrogenase and high mitochondrial glycerol phosphate dehydrogenase in pancreatic beta-cells. Potential role in nutrient sensing. , 1994, The Journal of biological chemistry.

[67]  R. Takayanagi,et al.  SMAD2 disruption in mouse pancreatic beta cells leads to islet hyperplasia and impaired insulin secretion due to the attenuation of ATP-sensitive K+ channel activity , 2013, Diabetologia.

[68]  A. F. Stewart,et al.  Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. , 2004, Diabetes.